APNA, AANA issue statement on ketamine infusion therapy
Mental Health Weekly November 13, 2023 DOI: 10.1002/mhw.33857 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Position statement or joint statement Peer reviewed |
|---|---|
| Intervention | Ketamine infusion therapy |
| Topics | Esketamine Ketamine |
| Key points | Patients with psychiatric disorders may benefit from ketamine infusion therapy. |
Abstract
Observing that ketamine infusion therapy is increasingly being used for such mental health conditions as major depressive disorder, bipolar disorder, treatment‐resistant depression, and post‐traumatic stress disorder, two national nursing associations have released a joint statement indicating that patients with psychiatric disorders may benefit from the use of ketamine infusion therapy.